These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10974047)

  • 41. Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development.
    Hiltunen TP; Luoma JS; Nikkari T; Ylä-Herttuala S
    Circulation; 1998 Mar; 97(11):1079-86. PubMed ID: 9531255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress.
    Tietge UJ; Pratico D; Ding T; Funk CD; Hildebrand RB; Van Berkel T; Van Eck M
    J Lipid Res; 2005 Aug; 46(8):1604-14. PubMed ID: 15897607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene.
    Arai T; Wang N; Bezouevski M; Welch C; Tall AR
    J Biol Chem; 1999 Jan; 274(4):2366-71. PubMed ID: 9891004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated expression of phospholipid transfer protein in bone marrow derived cells causes atherosclerosis.
    van Haperen R; Samyn H; Moerland M; van Gent T; Peeters M; Grosveld F; van Tol A; de Crom R
    PLoS One; 2008 May; 3(5):e2255. PubMed ID: 18509527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice.
    Pennings M; Hildebrand RB; Ye D; Kunne C; Van Berkel TJ; Groen AK; Van Eck M
    Cardiovasc Res; 2007 Oct; 76(1):175-83. PubMed ID: 17560559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals.
    Takahashi K; Takeya M; Sakashita N
    Med Electron Microsc; 2002 Dec; 35(4):179-203. PubMed ID: 12658354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of scavenger receptor class A in the adhesion of cells is dependent on cell type and cellular activation state.
    van Velzen AG; Suzuki H; Kodama T; van Berkel TJ
    Exp Cell Res; 1999 Jul; 250(1):264-71. PubMed ID: 10388540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Scavenger receptor class B type I in high-density lipoprotein metabolism, atherosclerosis and heart disease: lessons from gene-targeted mice.
    Trigatti B; Covey S; Rizvi A
    Biochem Soc Trans; 2004 Feb; 32(Pt 1):116-20. PubMed ID: 14748727
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages.
    Kunjathoor VV; Febbraio M; Podrez EA; Moore KJ; Andersson L; Koehn S; Rhee JS; Silverstein R; Hoff HF; Freeman MW
    J Biol Chem; 2002 Dec; 277(51):49982-8. PubMed ID: 12376530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Uptake and catabolism of modified LDL in scavenger-receptor class A type I/II knock-out mice.
    Van Berkel TJ; Van Velzen A; Kruijt JK; Suzuki H; Kodama T
    Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):29-35. PubMed ID: 9512458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The absence of macrophage Nrf2 promotes early atherogenesis.
    Ruotsalainen AK; Inkala M; Partanen ME; Lappalainen JP; Kansanen E; Mäkinen PI; Heinonen SE; Laitinen HM; Heikkilä J; Vatanen T; Hörkkö S; Yamamoto M; Ylä-Herttuala S; Jauhiainen M; Levonen AL
    Cardiovasc Res; 2013 Apr; 98(1):107-15. PubMed ID: 23341579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein.
    Marsche G; Zimmermann R; Horiuchi S; Tandon NN; Sattler W; Malle E
    J Biol Chem; 2003 Nov; 278(48):47562-70. PubMed ID: 12968020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis.
    Ren B; Van Kampen E; Van Berkel TJ; Cruickshank SM; Van Eck M
    Atherosclerosis; 2017 Jan; 256():35-46. PubMed ID: 27998825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrow.
    Baldán A; Pei L; Lee R; Tarr P; Tangirala RK; Weinstein MM; Frank J; Li AC; Tontonoz P; Edwards PA
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2301-7. PubMed ID: 16888235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluid-phase pinocytosis of native low density lipoprotein promotes murine M-CSF differentiated macrophage foam cell formation.
    Barthwal MK; Anzinger JJ; Xu Q; Bohnacker T; Wymann MP; Kruth HS
    PLoS One; 2013; 8(3):e58054. PubMed ID: 23536783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1-/- bone marrow.
    Ranalletta M; Wang N; Han S; Yvan-Charvet L; Welch C; Tall AR
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2308-15. PubMed ID: 16917103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Macrophage-expressed group IIA secretory phospholipase A2 increases atherosclerotic lesion formation in LDL receptor-deficient mice.
    Webb NR; Bostrom MA; Szilvassy SJ; van der Westhuyzen DR; Daugherty A; de Beer FC
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):263-8. PubMed ID: 12588769
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apolipoprotein E4 in macrophages enhances atherogenesis in a low density lipoprotein receptor-dependent manner.
    Altenburg M; Johnson L; Wilder J; Maeda N
    J Biol Chem; 2007 Mar; 282(11):7817-24. PubMed ID: 17234631
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SREC-I, a type F scavenger receptor, is an endocytic receptor for calreticulin.
    Berwin B; Delneste Y; Lovingood RV; Post SR; Pizzo SV
    J Biol Chem; 2004 Dec; 279(49):51250-7. PubMed ID: 15371419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice.
    Wang N; Arai T; Ji Y; Rinninger F; Tall AR
    J Biol Chem; 1998 Dec; 273(49):32920-6. PubMed ID: 9830042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.